Skip to main content
# Title Department Research Member Research Year
361 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2020
362 Analgesic Effect of Intrathecal Fentanyl vs Dexmedetomidine as Adjuvants to Bupivacaine Following Abdominal Surgery for Cancer in Children, a Randomized Trial Department of Anesthesia, Intensive care and Pain management Prof. Khaled Mohamed Fares Ali 2020
363 Adipocytokine, leptin, and resistin in combination with quantitative visceral adiposity as predictors of colorectal neoplasm: A case-control study Department of Clinical Pathology Dr. Engy adel shafeek 2020
364 2. The reliability of the computed
tomography perfusion parameters as a
predictor of colorectal cancer grade:
influence of tumor region of interest
position
Department of Radiotherapy and Nuclear medicine Dr. Mona Mahmoud Sayed 2020
365 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2020
366 The diagnostic efficacy of tailored multiparametric breast MRI in indeterminate mammographic lesions: A single tertiary oncology center Department of Radiotherapy and Nuclear medicine Dr. Dalia Osama Mohamed Ahmed 2020
367 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Department of Medical Oncology Rabab Mohammed Mamdouh Abdelhameed 2020
368 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? Department of Surgical Oncology Dr. Mahmoud Hussein Abdel-Azim Badawi 2020
369 The diagnostic efficacy of tailored multiparametric breast MRI in indeterminate mammographic lesions: A single tertiary oncology center Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2020
370 Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer Department of Medical Oncology Dr. Abeer Elsayed Ali Ibrahim 2020